Kidney Transplant Chain Saves Six Lives In Australia
Kidney Transplant Chains
In a kidney transplant chain like the one recently performed in Australia, a donor who wishes to give a kidney to a specific patient, but who is not a compatible match for that patient, gives his or her kidney to another person on the transplant list with whom the donor is compatible -- despite not knowing the recipient. That recipient also has a willing but incompatible donor, who donates a kidney to a compatible stranger since his or her intended recipient will be receiving an organ from the first patient’s originally intended donor. And so the chain continues, often removing several kidney failure patients from transplant wait lists in rapid succession.
If a single person in the chain had chosen not to participate or was unable to proceed with the operation, the entire process could have collapsed. One recipient had a mysterious mound on his leg, which was discovered just prior to the start of the surgeries. A biopsy was conducted in order to exclude a cancer diagnosis. Fortunately for everyone involved, it was simply a complication of the patient’s kidney failure.
A Team Effort Worth Repeating
The Australian Paired Kidney Exchange Program is a triumph for the transplant surgeons, doctors, nurses and other members of the medical team involved in the coordinated effort. It also testifies to the generosity of the live kidney donors who were able to help their loved ones by giving their organs to unknown recipients in the chain.
Some of the success of the paired exchanges must be attributed to the scientists who make the matches from a computer database. Dr. Paolo Ferrari, the Australian program’s director, likened it to using a dating agency to find a compatible match. Of course, preferences in this case would involve blood type instead of body type, and antibody levels instead of a fondness for long walks on the beach.
Altruistic kidney donors who initiate or participate in a transplant exchange program usually do not know who will receive their organs, but the life-changing effects reverberate. So far, the Organ and Tissue Authority program has made possible 92 transplants, a figure which could grow exponentially with a larger pool of potential matches.
Source: Herald Sun
Photo Credit: Google Images / The Health Site
Published on : Tue, 10 Jun 2014
Print as PDF
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...
The HAMILTON-C6 represents a new Generation of high-end ventilators. The combination of modularity, ease of use, mobility, and advanced features allows you to individualize your patient's ventilation therapy: - State-of-the-art ventilation modes for adult,...
FeaturesMindray BeneVision Central Monitoring System is a powerful and scalable solution providing for continuous, real-time surveillance across networks large and small. The system can display patient information from networked monitors, wireless transport...